# Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction

> **NCT06544447** · PHASE1,PHASE2 · RECRUITING · sponsor: **Beijing Tongren Hospital** · enrollment: 135 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DEVICE:** taVNS
- **DRUG:** Hyaluronic acid eye drops

## Key facts

- **NCT ID:** NCT06544447
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544447, "Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06544447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*